A Phase 2 Study of Dalantercept, an Activin Receptor-Like Kinase-1 Ligand Trap, in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. Cancer. December 1, 2016; 122(23):3641-3649

Click here for access to the full publication in the December 1st issue (volume 122, issue #23) of Cancer, a journal of the American Cancer Society